Mitochondrial translation initiation factor 3 gene polymorphism associated with Parkinson's disease

Neuroscience Letters

Volumn 414, Issue 2, 2007, Pages 126-129

  Abahuni, Nadine ^a   Gispert, Suzana ^a   Bauer, Peter ^b   Riess, Olaf ^b   Krüger, Rejko ^c   Becker, Tim ^d   Auburger, Georg ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

Mitochondria; MTIF3; Parkinson's disease; Polymorphism

Indexed keywords

GENOMIC DNA; INITIATION FACTOR 3;

ARTICLE; BRAIN MITOCHONDRION; CASE CONTROL STUDY; CONTROLLED STUDY; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 33847019962     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.12.053     Document Type: Article

References (29)

1. Chung K.K., Zhang Y., Lim K.L., Tanaka Y., Huang H., Gao J., Ross C.A., Dawson V.L., and Dawson T.M. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat. Med. 7 (2001) 1144-1150
2. Clark I.E., Dodson M.W., Jiang C., Cao J.H., Huh J.R., Seol J.H., Yoo S.J., Hay B.A., and Guo M. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature (2006)
3. Drew P.D., Nagle J.W., Canning R.D., Ozato K., Biddison W.E., and Becker K.G. Cloning expression analysis of a human cDNA homologous to Xenopus TFIIIA. Gene 159 (1995) 215-218
4. Elbaz A., Nelson L.M., Payami H., Ioannidis J.P., Fiske B.K., Annesi G., Carmine Belin A., Factor S.A., Ferrarese C., Hadjigeorgiou G.M., Higgins D.S., Kawakami H., Kruger R., Marder K.S., Mayeux R.P., Mellick G.D., Nutt J.G., Ritz B., Samii A., Tanner C.M., Van Broeckhoven C., Van Den Eeden S.K., Wirdefeldt K., Zabetian C.P., Dehem M., Montimurro J.S., Southwick A., Myers R.M., and Trikalinos T.A. Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. Lancet Neurol. 5 (2006) 917-923
5. Gibb W.R., and Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 51 (1988) 745-752
6. Gispert S., Trenkwalder C., Mota-Vieira L., Kostic V., and Auburger G. Failure to find alpha-synuclein gene dosage changes in 190 patients with familial Parkinson disease. Arch. Neurol. 62 (2005) 96-98
7. Greene J.C., Whitworth A.J., Andrews L.A., Parker T.J., and Pallanck L.J. Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis. Hum. Mol. Genet. 14 (2005) 799-811
8. Hering R., Petrovic S., Mietz E.M., Holzmann C., Berg D., Bauer P., Woitalla D., Muller T., Berger K., Kruger R., and Riess O. Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease. Neurology 62 (2004) 1231-1232
9. Jenner P. Oxidative stress in Parkinson's disease. Ann. Neurol. 53 Suppl. 3 (2003) S26-S36 discussion S36-8
10. Koc E.C., and Spremulli L.L. Identification of mammalian mitochondrial translational initiation factor 3 and examination of its role in initiation complex formation with natural mRNAs. J. Biol. Chem. 277 (2002) 35541-35549
11. Langston J.W., Ballard P., Tetrud J.W., and Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219 (1983) 979-980
12. Maraganore D.M. Blood is thicker than water: the strengths of family-based case-control studies. Neurology 64 (2005) 408-409
13. Maraganore D.M., de Andrade M., Lesnick T.G., Strain K.J., Farrer M.J., Rocca W.A., Pant P.V., Frazer K.A., Cox D.R., and Ballinger D.G. High-resolution whole-genome association study of Parkinson disease. Am. J. Hum. Genet. 77 (2005) 685-693
14. Moore D.J., West A.B., Dawson V.L., and Dawson T.M. Molecular pathophysiology of Parkinson's disease. Annu. Rev. Neurosci. 28 (2005) 57-87
15. Moore D.J., Zhang L., Troncoso J., Lee M.K., Hattori N., Mizuno Y., Dawson T.M., and Dawson V.L. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. Hum. Mol. Genet. 14 (2005) 71-84
16. Park J., Kim S.Y., Cha G.H., Lee S.B., Kim S., and Chung J. Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction. Gene 361 (2005) 133-139
17. Park J., Lee S.B., Lee S., Kim Y., Song S., Kim S., Bae E., Kim J., Shong M., Kim J.M., and Chung J. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature (2006)
18. Pesah Y., Pham T., Burgess H., Middlebrooks B., Verstreken P., Zhou Y., Harding M., Bellen H., and Mardon G. Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development 131 (2004) 2183-2194
19. Risch N. Implications of multilocus inheritance for gene-disease association studies. Theor. Popul. Biol. 60 (2001) 215-220
20. Rotig A., and Munnich A. Genetic features of mitochondrial respiratory chain disorders. J. Am. Soc. Nephrol. 14 (2003) 2995-3007
21. Schapira A.H., Cooper J.M., Dexter D., Clark J.B., Jenner P., and Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54 (1990) 823-827
22. Silvestri L., Caputo V., Bellacchio E., Atorino L., Dallapiccola B., Valente E.M., and Casari G. Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive Parkinsonism. Hum. Mol. Genet. 14 (2005) 3477-3492
23. Smith W.W., Pei Z., Jiang H., Moore D.J., Liang Y., West A.B., Dawson V.L., Dawson T.M., and Ross C.A. Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 18676-18681
24. Strauss K.M., Martins L.M., Plun-Favreau H., Marx F.P., Kautzmann S., Berg D., Gasser T., Wszolek Z., Muller T., Bornemann A., Wolburg H., Downward J., Riess O., Schulz J.B., and Kruger R. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum. Mol. Genet. 14 (2005) 2099-2111
25. Tu I.P., and Whittemore A.S. Power of association and linkage tests when the disease alleles are unobserved. Am. J. Hum. Genet. 64 (1999) 641-649
26. Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A.R., Healy D.G., Albanese A., Nussbaum R., Gonzalez-Maldonado R., Deller T., Salvi S., Cortelli P., Gilks W.P., Latchman D.S., Harvey R.J., Dallapiccola B., Auburger G., and Wood N.W. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304 (2004) 1158-1160
27. van der Walt J.M., Nicodemus K.K., Martin E.R., Scott W.K., Nance M.A., Watts R.L., Hubble J.P., Haines J.L., Koller W.C., Lyons K., Pahwa R., Stern M.B., Colcher A., Hiner B.C., Jankovic J., Ondo W.G., Allen Jr. F.H., Goetz C.G., Small G.W., Mastaglia F., Stajich J.M., McLaurin A.C., Middleton L.T., Scott B.L., Schmechel D.E., Pericak-Vance M.A., and Vance J.M. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am. J. Hum. Genet. 72 (2003) 804-811
28. Ved R., Saha S., Westlund B., Perier C., Burnam L., Sluder A., Hoener M., Rodrigues C.M., Alfonso A., Steer C., Liu L., Przedborski S., and Wolozin B. Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans. J. Biol. Chem. 280 (2005) 42655-42668
29. Yang Y., Gehrke S., Haque M.E., Imai Y., Kosek J., Yang L., Beal M.F., Nishimura I., Wakamatsu K., Ito S., Takahashi R., and Lu B. Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 13670-13675